Skip to content
中文产业新闻评分54Chinese source

诺和诺德26亿美元拿下恒瑞临床前GLP-1/GIP双激动剂HRS-1596

26亿美元!诺和买下恒瑞一款临床前GLP-1/GIP

No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.